News 2 June 2026 - 3 June 2026

Etihad Orders 10 Boeing Jets, Raising Talk of Hard-to-Get 787 Slots
·······

Stock Market Today: Live Updates 13.07.2026

LIVEMarkets rolling coverageStarted: July 13, 2026, 4:00 AM EDTUpdated: July 13, 2026, 6:04 AM EDT Genflow Biosciences Sees Ongoing Longevity Benefits in Dog Gene Therapy Study July 13, 2026, 5:55 AM EDT. Genflow Biosciences Ltd (LSE:GENF) said its SLAB aged-dog gene therapy trial is still showing longevity improvements at the three-month checkpoint. The results look steady, with the therapy holding up. Investors are watching as biotech groups turn more to animal health. The stock trades on other markets like OTCQB and FRA. Genflow Biosciences dog trial continues to show longevity improvements Beacon Rise Holdings PLC Secures £50,000 Through Subscription Agreement
July 13, 2026
Broadwind Shares Climb 8% as Traders Return to Small Manufacturer
····

Broadwind Shares Climb 8% as Traders Return to Small Manufacturer

Broadwind Inc. shares gained 8.1% Tuesday to finish at $4.02 on Nasdaq, with the Illinois-based manufacturer picking up trading interest following its big shift away from wind tower production. After hours, the stock slipped to $3.98. Broadwind is trading more as a niche precision manufacturer than a pure wind-market player now. The company’s market value stood at around $94 million, putting it in micro-cap territory. About 442,000 shares changed hands in recent trade, the data show.
June 3, 2026
Chemomab Drops After Board Changes and CEO Stock Purchase
····

Chemomab Drops After Board Changes and CEO Stock Purchase

Chemomab Therapeutics’ American depositary shares on Nasdaq were last down 6.5% at $1.74 Tuesday. The move trailed a down biotech sector, after a June 2 regulatory filing showed board and committee changes at the Israeli drug developer. Shares opened at $1.95, hitting a low of $1.74. An ADS is a U.S. receipt for foreign shares. Chemomab is working to push nebokitug, its top antibody, into possible late-stage testing for primary sclerosing cholangitis, or PSC. With the stock thin and cash limited, who's on the board and the status of any partner talks can be nearly as important as what the shares do each day.
June 2, 2026
Sify Shares Stuck, India AI Data-Center Bet Draws Traders
····

Sify Shares Stuck, India AI Data-Center Bet Draws Traders

Sify Technologies Limited’s American depositary receipts trading in the U.S. ended Tuesday mostly unchanged. The stock stalled after choppy moves, as investors considered the Indian digital infrastructure group's ongoing data-center expansion against bigger losses and rising debt. Sify ADRs were last at $17.24, up 0.12%, trading 82,064 shares, market data showed. An ADR, or American depositary receipt, is a certificate traded in the U.S. that stands for shares of a foreign company.
June 2, 2026
Marchex Shares Steady With Investors Watching AI Deal Vote
····

Marchex Shares Steady With Investors Watching AI Deal Vote

Marchex Inc. drifted down in late U.S. trading Tuesday. The shares closed at $1.64, off 1 cent from the last session. The thinly traded AI conversation-intelligence stock had volume of 11,961 shares, market data showed. Investors saw little new out of the company. The pending acquisition stayed in focus. That’s relevant now since Marchex hasn’t issued any fresh releases to its investor-news feed in the last 24 to 48 hours. The latest updates are still a May 13 first-quarter results release and a May 12 product announcement. So the immediate question stays on execution—if its Archenia deal and new AI products can drive revenue growth without piling on dilution or more integration risk.
June 2, 2026
DiaMedica Shares Down Ahead of Stroke Trial Update
····

DiaMedica Shares Down Ahead of Stroke Trial Update

DiaMedica Therapeutics Inc. shares fell Tuesday, with the drug developer closing lower as the major indexes gained. The stock was last at $5.77 after hours, off 6 cents from its close. It traded between $6.29 and $5.56 earlier in the session. Volume reached about 152,000 shares. Market cap was roughly $311 million. DiaMedica is heading into a catalyst week as it prepares to present at 3:45 p.m. ET Thursday during the Jefferies Global Healthcare Conference in New York. The event, which runs June 2-4, draws attention from healthcare investors looking for pipeline news and signs of financing.
June 2, 2026
Aura Biosciences Stock Falls After Eye-Cancer Trial News
····

Aura Biosciences Stock Falls After Eye-Cancer Trial News

Aura Biosciences shares dropped roughly 4.2% to $6.89 late Tuesday, lagging a soft biotech sector. This came after Aura said on Monday that it hit a clinical-trial milestone. The SPDR S&P Biotech ETF slid about 4.2%. The iShares Nasdaq Biotechnology ETF lost around 2.9%. Aura said Monday it finished enrolling 108 patients in CoMpass, its Phase 3 study of bel-sar for early choroidal melanoma. Phase 3 trials are key late-stage tests before a drug approval. The first main results, or “topline” data, are due in the second half of 2027.
June 2, 2026
Myseum.AI Drops as AI Rebrand Hype Meets Cash Worries
····

Myseum.AI Drops as AI Rebrand Hype Meets Cash Worries

Myseum.AI shares dropped Tuesday. The small privacy-focused social media firm is still under pressure, just weeks after an AI rebrand sent it into speculative territory for a short stretch. The stock finished at $1.67, off 10 cents, or 5.65%, based on StockAnalysis market data. StockAnalysis gave Myseum.AI’s market cap at about $7.18 million, putting it in the nano-cap category—one of the smallest public company tiers.
June 2, 2026
LifeMD Up After Hiring AI-Focused CTO, Telehealth Competition Grows
····

LifeMD Up After Hiring AI-Focused CTO, Telehealth Competition Grows

LifeMD shares finished up Tuesday. The telehealth company tapped Umesh Sripad as CTO. Sripad has digital exec experience at PetMeds, IKEA USA and Bed Bath & Beyond. He’ll oversee AI, cybersecurity and data systems at LifeMD. The shares closed 1.3% higher at $4.69 on Nasdaq, moving between $4.54 and $4.80 through the day. Google Finance listed the market cap close to $225 million.
June 2, 2026
Ondas Stock Climbs After Navy Balloon Deal — Why ONDS Is Back in Focus
····

Ondas Stock Climbs After Navy Balloon Deal — Why ONDS Is Back in Focus

Ondas Inc. shares were last quoted up about 2% at $13.76 just before Tuesday’s U.S. close, after the defense-technology company said its World View unit had been picked for a U.S. Navy-linked maritime surveillance program. The stock traded between $13.11 and $14.15, with volume above 80 million shares. The move came on a mixed tape. Reuters market data showed the S&P 500 slightly higher and the Nasdaq Composite slightly lower around the same period, keeping the day’s focus on company-specific defense and drone news rather than a broad market lift.
June 2, 2026
Sohu Gains as Traders Watch Cash and Buybacks; China Gaming Cools
····

Sohu Gains as Traders Watch Cash and Buybacks; China Gaming Cools

Sohu.com Limited’s U.S. shares edged higher Tuesday afternoon, gaining 0.8% to $13.93 on light volume. The move came as investors focused on the company’s most recent earnings rather than new headlines. Shares traded in a range from $13.55 to $13.99, with volume a little above 33,000. Sohu, a smaller Chinese internet and gaming stock on Nasdaq, is moving mostly on its last update, not fresh news. Timing is key here. Nasdaq trades from 9:30 a.m. to 4 p.m. Eastern, and June 2 shows up as a regular trading day for 2026.
June 2, 2026
TRG Latin America Stock Quiet at $10 Mark as Activity Stalls
····

TRG Latin America Stock Quiet at $10 Mark as Activity Stalls

TRG Latin America Acquisitions Corp. shares didn’t trade on Nasdaq Tuesday, staying at $9.87 on Robinhood as of June 2. Volume stayed at zero for the session, leaving the blank-check company quiet as it seeks a merger. A different feed listed a $9.90 quote, but the last trade was May 28. That’s important now since TRG Latin America isn’t an operating company. It’s a special purpose acquisition company, or SPAC—a listed shell that collects cash and looks to buy a private firm. The stock tends to trade more on trust value, deal expectations and liquidity than on earnings.
June 2, 2026
Millicom Tigo jumps to new peak as $3 dividend gets attention
····

Millicom Tigo jumps to new peak as $3 dividend gets attention

Millicom International Cellular’s U.S. shares jumped 3.6% to $88.89 Tuesday afternoon, hitting that level for the session high. Investors kept leaning into the Latin America telecom’s cash-return angle. About 913,000 shares changed hands, putting the company’s market value near $15.3 billion. Millicom shares had already set a 52-week high at $87.31 on Monday, Investing.com said, and the stock had more than doubled over the last year. It broke above that high again on Tuesday.
June 2, 2026
Mama’s Creations Investors Track MAMA Stock Before Earnings
····

Mama’s Creations Investors Track MAMA Stock Before Earnings

Mama’s Creations Inc gained 27 cents to $14.52 in Tuesday’s afternoon session, up around 1.9%. Shares picked up ahead of next week’s earnings report. The stock outperformed the consumer-staples ETF XLP, which slipped about 0.1%. Timing is key. Mama’s Creations will report fiscal Q1 2027 results after the close on June 8, with a 4:30 p.m. Eastern conference call. Investors want to see if gains from new distribution and the Crown 1 deal show up as steady sales or if the boost is limited to just one quarter.
June 2, 2026
Sabre Drops as AI Plays Drive Wall Street; Investors Look to What’s Next
····

Sabre Drops as AI Plays Drive Wall Street; Investors Look to What’s Next

Sabre Corporation shares slipped in Tuesday’s afternoon session, trailing the broader Wall Street gains. There was little new from the company ahead of the next public investor event, so trading volume was light. Sabre shares last traded at $1.88, off 0.5%. The stock saw a range from $1.815 to $1.90 on Nasdaq. Around 1.66 million shares changed hands. Market value for the company was about $747 million, market data showed.
June 2, 2026
Neuronetics Stock Drops As Traders Watch New TMS Research Effort
·····

Neuronetics Stock Drops As Traders Watch New TMS Research Effort

Neuronetics Inc. dropped 5.7% to $1.575 Tuesday. This comes after the company announced that new NeuroStar data will be presented this week at a big transcranial magnetic stimulation conference. NEUR opened at $1.67, hit $1.76 before slipping to around $1.57, with volume near 785,000 shares. Timing is key here. Neuronetics wants to prove its NeuroStar system has stronger evidence behind it, even as the company deals with a balance-sheet crunch. Transcranial magnetic stimulation, or TMS, is a non-invasive therapy that uses magnetic pulses on specific brain regions, usually for patients whose depression hasn’t responded to medication.
June 2, 2026
Design Therapeutics Drops Ahead of Jefferies, Trial Remains in Focus for DSGN
····

Design Therapeutics Drops Ahead of Jefferies, Trial Remains in Focus for DSGN

Design Therapeutics shares slid on Tuesday afternoon, dropping 24 cents to $10.20 in a broader biotech selloff. The Carlsbad, California-based firm was off roughly 2.3%. The SPDR S&P Biotech ETF lost about 4.0%, and the iShares Nasdaq Biotechnology ETF slipped about 3.0%. Design shares are in focus again since there’s been no new trial data update. The most recent post on Design’s investor page is still the May 28 Jefferies conference notice. Management is slated for a fireside chat in New York on June 4 at 1:25 p.m. EDT.
June 2, 2026
FGI Stock Alert: Tiny Kitchen-and-Bath Supplier Near Flat Before Wednesday Shareholder Vote
····

FGI Stock Alert: Tiny Kitchen-and-Bath Supplier Near Flat Before Wednesday Shareholder Vote

FGI Industries Ltd. shares were little changed in Nasdaq trading on Tuesday afternoon, last changing hands at $5.86, up 3 cents, or about 0.5%, in a quote timestamped 11:48 a.m. EDT. The company’s market value was about $11.3 million, putting it in micro-cap territory — a small public-market value where modest trades can move the price. The timing matters because shareholders vote on Wednesday. FGI’s proxy sets a June 3 virtual annual meeting at 9 a.m. Eastern time to elect five directors and ratify Marcum Asia CPAs LLP as auditor for fiscal 2026.
June 2, 2026
Option Care Health Shares Edge Higher, Market Focuses on Outlook
····

Option Care Health Shares Edge Higher, Market Focuses on Outlook

Option Care Health ticked just above flat Tuesday afternoon after the home-infusion provider said it was ranked No. 15 on TIME’s 2026 list of the world’s most impactful companies. The stock traded 0.1% higher at $20.49, volume near 528,000 shares. It moved between $20.21 and $20.64. The QQQ ETF, which tracks the Nasdaq, gained 0.4%. Health Care Select Sector SPDR Fund, which covers the sector, slipped 1.1%.
June 2, 2026
Liberty Broadband Slides; Market Focuses on Charter Deal Figure
·····

Liberty Broadband Slides; Market Focuses on Charter Deal Figure

Liberty Broadband Corp Class C shares slid midday Tuesday. The stock tracked Charter Communications as traders continued to price Liberty Broadband off Charter’s all-stock deal terms instead of any new update from the company. Nasdaq: The Class C shares slipped 0.9% to $33.13. Liberty Broadband’s Class A stock dropped 0.8% to $33.09. Charter, its major holding and the expected buyer, lost 0.8% at $141.46.
June 2, 2026
Vendome Shares Hold Steady, Focus Shifts to $205.6 Million Trust
····

Vendome Shares Hold Steady, Focus Shifts to $205.6 Million Trust

Vendome Acquisition Corporation I stock was flat at $10.19 early Tuesday afternoon. Shares hovered near the usual cash trust price for SPACs waiting to announce a deal. As of 1:04 p.m. EDT, VNME was unchanged on the Nasdaq, according to StockAnalysis. That’s important now since Vendome is still a special purpose acquisition company, or SPAC—a listed shell company that raises cash first, then looks for a merger. For stocks like these, short-term focus stays on the trust account, redemption price, and the time the sponsor has left to make a deal, rather than sales or margins.
June 2, 2026
1 … 122 123 124 125 126 … 492